MPH Medicure Inc.
2.930CAD+0.34%Mkt Cap: 22.27M $P/E: —1d ago
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.69BUSDP/E 25.5
$57.82BUSD
$45.64BUSDP/E 65.2
$39.01BUSDP/E 18.1
$29.48BUSDP/E 11.7
$28.56BUSDP/E 12.2
$23.23BUSDP/E 19.4
$20.15BUSD
$14.27BUSDP/E 111.6
$14.79BUSDP/E 21.3
$12.60BUSDP/E 22.8
$11.23BUSD
$10.40BUSDP/E 28.4
$8.63BUSDP/E 19.3
$7.07BUSDP/E 41.4
$6.99BUSDP/E 109.6
$6.88BUSD
$6.53BUSDP/E 24.2
$5.93BUSDP/E 77.9
$5.27BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Medicure Inc (MCUJF) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic Expansion ... Medicure Inc (MCUJF) reports a 10% revenue increase to $7.4 million, driven by ZYPITAMAG and pharmacy acquisitions, despite a widened net loss from a one-time CMS assessment. | ||